Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment Adherence to JNC 7(Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, 7th Report) Guidelines in Cardiovascular (CV)-Risk Patients Across the Middle East - the Impact of Ramadan Fasting on Achieving Treatment Goals in Daily Practice

NCT01853839 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT01853839
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01853839 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment Adherence to JNC 7(Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, 7th Report) Guidelines in Cardiovascular (CV)-Risk Patients Across the Middle East - the Impact of Ramadan Fasting on Achieving Treatment Goals in Daily Practice
Lead sponsor
Boehringer Ingelheim
Phase
Observational
Overall status
Completed
Start date
October 31, 2011
Completion date
July 31, 2014
Enrollment
1,674 (actual)
Sites
132

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension